Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,919,358
-
Share change
-
-71,852
-
Total reported value
-
$5,529,516
-
Price per share
-
$2.88
-
Number of holders
-
17
-
Value change
-
-$253,984
-
Number of buys
-
4
-
Number of sells
-
18
Institutional Holders of ACER THERAPEUTICS INC - COM (ACER) as of Q3 2020
As of 30 Sep 2020,
ACER THERAPEUTICS INC - COM (ACER) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,919,358 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, Worth Venture Partners, LLC, VANGUARD GROUP INC, FEDERATED HERMES, INC., BlackRock Inc., GSA CAPITAL PARTNERS LLP, BARCLAYS PLC, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, and NORTHERN TRUST CORP.
This page lists
17
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.